4C Medical Technologies, Inc
Last verified 2026-05-20. JSON
| Total raised | $71.6M |
|---|---|
| Latest round | Funding round, $71.6M, 2026-03-04 |
| Founded | 2014 |
| Headquarters | Maple Grove, MN |
| Industry | health care |
| Stage | unknown |
| Website | 4cmed.com |
4C Medical develops minimally invasive technology for treating mitral regurgitation, led by its AltaValve transcatheter mitral valve replacement. It serves patients with mitral regurgitation who need a less invasive alternative to surgery. AltaValve uses a supra-annular design that preserves critical cardiac structures.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-03-04 | Funding round | $71.6M | undisclosed |
Detected tech stack
Typekit, Adobe Fonts, Afterpay, Sentry, Squarespace, Squarespace Commerce, Stimulus, web-vitals, moment 0, @sentry/browser
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $71.6M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $71.6M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | 4cmed.com, read 2026-05-20 |
| Description | self-reported | 4cmed.com, read 2026-05-20 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $71.6M, 2026-03-04 → Funding round, $71.6M, 2026-03-04, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $71.6M, 2026-03-04 → Funding round, $71.6M, 2026-03-04 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes